350 related articles for article (PubMed ID: 19821032)
1. Neuroinflammation in Parkinson's disease.
Lee JK; Tran T; Tansey MG
J Neuroimmune Pharmacol; 2009 Dec; 4(4):419-29. PubMed ID: 19821032
[TBL] [Abstract][Full Text] [Related]
2. The Contribution of Microglia to Neuroinflammation in Parkinson's Disease.
Badanjak K; Fixemer S; Smajić S; Skupin A; Grünewald A
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925154
[TBL] [Abstract][Full Text] [Related]
3. Neuroinflammation in Parkinson's disease: role in neurodegeneration and tissue repair.
Vivekanantham S; Shah S; Dewji R; Dewji A; Khatri C; Ologunde R
Int J Neurosci; 2015; 125(10):717-25. PubMed ID: 25364880
[TBL] [Abstract][Full Text] [Related]
4. Pathological α-synuclein exacerbates the progression of Parkinson's disease through microglial activation.
Zhang QS; Heng Y; Yuan YH; Chen NH
Toxicol Lett; 2017 Jan; 265():30-37. PubMed ID: 27865851
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
6. IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease.
Liu Z; Qiu AW; Huang Y; Yang Y; Chen JN; Gu TT; Cao BB; Qiu YH; Peng YP
Brain Behav Immun; 2019 Oct; 81():630-645. PubMed ID: 31351185
[TBL] [Abstract][Full Text] [Related]
7. Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease.
Gao HM; Zhang F; Zhou H; Kam W; Wilson B; Hong JS
Environ Health Perspect; 2011 Jun; 119(6):807-14. PubMed ID: 21245015
[TBL] [Abstract][Full Text] [Related]
8. Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disease.
Marogianni C; Sokratous M; Dardiotis E; Hadjigeorgiou GM; Bogdanos D; Xiromerisiou G
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182554
[TBL] [Abstract][Full Text] [Related]
9. The role of innate immunity and inflammation in Parkinson´s disease.
Öberg M; Fabrik I; Fabrikova D; Zehetner N; Härtlova A
Scand J Immunol; 2021 May; 93(5):e13022. PubMed ID: 33471378
[TBL] [Abstract][Full Text] [Related]
10. The potential role of neuroinflammation and transcription factors in Parkinson disease.
Tiwari PC; Pal R
Dialogues Clin Neurosci; 2017 Mar; 19(1):71-80. PubMed ID: 28566949
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.
Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN
J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665
[TBL] [Abstract][Full Text] [Related]
12. TLR4 absence reduces neuroinflammation and inflammasome activation in Parkinson's diseases in vivo model.
Campolo M; Paterniti I; Siracusa R; Filippone A; Esposito E; Cuzzocrea S
Brain Behav Immun; 2019 Feb; 76():236-247. PubMed ID: 30550933
[TBL] [Abstract][Full Text] [Related]
13. Neuroinflammation in Parkinson's disease: is there sufficient evidence for mechanism-based interventional therapy?
Tansey MG; Frank-Cannon TC; McCoy MK; Lee JK; Martinez TN; McAlpine FE; Ruhn KA; Tran TA
Front Biosci; 2008 Jan; 13():709-17. PubMed ID: 17981581
[TBL] [Abstract][Full Text] [Related]
14. T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease.
Campos-Acuña J; Elgueta D; Pacheco R
Front Immunol; 2019; 10():239. PubMed ID: 30828335
[TBL] [Abstract][Full Text] [Related]
15. Advances in NURR1-Regulated Neuroinflammation Associated with Parkinson's Disease.
Al-Nusaif M; Lin Y; Li T; Cheng C; Le W
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555826
[TBL] [Abstract][Full Text] [Related]
16. Updates on immunity and inflammation in Parkinson disease pathology.
Joshi N; Singh S
J Neurosci Res; 2018 Mar; 96(3):379-390. PubMed ID: 29072332
[TBL] [Abstract][Full Text] [Related]
17. Parkinson's disease: Autoimmunity and neuroinflammation.
De Virgilio A; Greco A; Fabbrini G; Inghilleri M; Rizzo MI; Gallo A; Conte M; Rosato C; Ciniglio Appiani M; de Vincentiis M
Autoimmun Rev; 2016 Oct; 15(10):1005-11. PubMed ID: 27497913
[TBL] [Abstract][Full Text] [Related]
18. Lycopodium Attenuates Loss of Dopaminergic Neurons by Suppressing Oxidative Stress and Neuroinflammation in a Rat Model of Parkinson's Disease.
Jayaraj RL; Beiram R; Azimullah S; Meeran MFN; Ojha SK; Adem A; Jalal FY
Molecules; 2019 Jun; 24(11):. PubMed ID: 31185705
[TBL] [Abstract][Full Text] [Related]
19. A possible role for humoral immunity in the pathogenesis of Parkinson's disease.
Orr CF; Rowe DB; Mizuno Y; Mori H; Halliday GM
Brain; 2005 Nov; 128(Pt 11):2665-74. PubMed ID: 16219675
[TBL] [Abstract][Full Text] [Related]
20. An inflammatory review of Parkinson's disease.
Orr CF; Rowe DB; Halliday GM
Prog Neurobiol; 2002 Dec; 68(5):325-40. PubMed ID: 12531233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
